Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Mitchell, Andrew
2004.
Evaluating Pharmaceuticals for Health Policy and Reimbursement.
p.
190.
Drummond, Michael
2004.
Economic Evaluation in Health Care: Is It Really Useful or Are We Just Kidding Ourselves?.
Australian Economic Review,
Vol. 37,
Issue. 1,
p.
3.
Neumann, Peter J.
2005.
The Arrival of Economic Evidence in Managed Care Formulary Decisions.
Medical Care,
Vol. 43,
Issue. 7,
p.
II.
Neumann, Peter J.
Rosen, Allison B.
and
Weinstein, Milton C.
2005.
Medicare and Cost-Effectiveness Analysis.
New England Journal of Medicine,
Vol. 353,
Issue. 14,
p.
1516.
Whitty, Jennifer A.
Rundle‐Thiele, Sharyn R.
and
Scuffham, Paul A.
2008.
Insights into public preferences for pharmaceutical funding.
International Journal of Pharmaceutical and Healthcare Marketing,
Vol. 2,
Issue. 3,
p.
216.
Raftery, James P
2008.
Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand.
Medical Journal of Australia,
Vol. 188,
Issue. 1,
p.
26.
Schlander, Michael
2008.
Has NICE got it right?.
Current Medical Research and Opinion,
Vol. 24,
Issue. 4,
p.
951.
Gallego, Gisselle
van Gool, Kees
and
Kelleher, Dianne
2009.
Resource allocation and health technology assessment in Australia: Views from the local level.
International Journal of Technology Assessment in Health Care,
Vol. 25,
Issue. 02,
p.
134.
Littlejohns, Peter
Clark, Sarah
and
Weale, Albert
2012.
Social values in health priority setting: a conceptual framework.
Journal of Health Organization and Management,
Vol. 26,
Issue. 3,
p.
293.
Whitty, Jennifer A.
Rundle-Thiele, Sharyn R.
and
Scuffham, Paul A.
2012.
Insights from Triangulation of Two Purchase Choice Elicitation Methods to Predict Social Decision Making in Healthcare.
Applied Health Economics and Health Policy,
Vol. 10,
Issue. 2,
p.
113.
Whitty, Jennifer A.
and
Littlejohns, Peter
2015.
Social values and health priority setting in Australia: An analysis applied to the context of health technology assessment.
Health Policy,
Vol. 119,
Issue. 2,
p.
127.